16alpha-羟基泼尼松龙
16alpha-hydroxyprednisolone;11a,16b,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione;16α-hydroxy-prednisolone;16a-Hydroxyprednisolone;16α-Hydroxyprednisolone;(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-Trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one;11B,16A,17A,21-TETRAHYDROXYPREGNA-1,4-DIENE-3,20-DIONE;11β,16α,17α,21-Tetra;11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione;16α-hydroxy-prednisonlone;16b;20-dione;4-diene-3;Einecs 237-731-1;Budesonide impurity A;16a-Hydroxypredisolone;16α-Hydroxyprednisolon;16A-HYDROXY-PREDNISOLONE;Budesonide EP Impurity A;(8R,9R,10S,11R,13R,14R,16S,17R)-11,16,17-Trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,;C21H28O6;Pregna-1,4-diene-3,20-dione, 11,16,17,21-tetrahydroxy-, (11b,16a)-;OH-PRED;A807552;BCP0726000097;13951-70-7;11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione (16alpha-Hydroxyprednisolone);Q-101381;Pregna-1,4-diene-3,20-dione, 11,16,17,21-tetrahydroxy-, (11beta,16alpha)-;A-hydroxy-prednisolone;16alpha-Hydroxyprednisolone;11b,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione;BCP04133;11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione; Budesonide Imp. A (EP); 16alpha-Hydroxyprednisolone; Budesonide Impurity A;UNII-SW97540DC2;(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one;HY-117580;BCP9000061;Q27289433;AC1111;11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione;EINECS 237-731-1;11?,16?,17?,21-Tetrahydroxypregna-1,4-diene-3,20-dione;16alpha-Hydroxyprednisolone (11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione);CHEMBL3542319;Pregna-1,4-diene-3,20-dione, 11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-;DTXSID20930496;SEKYBDYVXDAYPY-ILNISADRSA-N;16.ALPHA.-HYDROXYPREDNISOLONE;CS-0066553;MFCD00872019;11-Beta,16-Alpha,17-Alpha,21-Tetrahydroxypregna-1,4-diene-3,20-dione;(9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one;A-Hydroxyprednisolone;(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;16alpha-Hydroxy-prednisonlone;11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione;AKOS025286083;SW97540DC2;EC 237-731-1;BUDESONIDE IMPURITY A [EP IMPURITY];(11beta,16alpha)-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;(11?,16?)-11,16,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione;16;SCHEMBL145096